BIO-1262

N/A

Report date: 2023/01/14 15:18:48
NME

Base Information

Drug NameBIO-1262
Drug Alias NameBIO-1262SNG-203BIO-1262/SNG-203
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsSolid tumoursLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBioArdis LLC
China Registration ClassN/A

Develop Information

Active CompaniesBioArdis LLCShenogen Pharma Group LtdBeijing Shenogen Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A